TERT and cancer: Recent studies have demonstrated that TRF2 binds the TERT promoter G-quadruplex and recruits the polycomb-repressor EZH2/PRC2 complex causing H3K27 trimethylation and TERT promoter repression both in cancer and normal cells (Sharma et al., 2021).